{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:15:21Z","timestamp":1788419721771,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"DOI":"10.1038\/s41375-026-03048-4","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:36:10Z","timestamp":1788417370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of clonal hematopoiesis in aplastic anemia under immunosuppressive therapy"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0473-6773","authenticated-orcid":false,"given":"Linzhu","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuechen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7936-053X","authenticated-orcid":false,"given":"Liwei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8531-0483","authenticated-orcid":false,"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"3048_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS. Aplastic Anemia. N Engl J Med. 2018;379:1643\u201356.","journal-title":"N Engl J Med"},{"key":"3048_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood.2019000940","volume":"136","author":"L Sun","year":"2020","unstructured":"Sun L, Babushok DV. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. 2020;136:36\u201349.","journal-title":"Blood"},{"key":"3048_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/10428194.2023.2215614","volume":"64","author":"C Gurnari","year":"2023","unstructured":"Gurnari C, Pagliuca S, Maciejewski JP. Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? Leuk Lymphoma. 2023;64:1389\u201399.","journal-title":"Leuk Lymphoma"},{"key":"3048_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2204617","volume":"28","author":"J Li","year":"2023","unstructured":"Li J, Li X, Cai L, Peng X, Yao M, Li S, et al. Prognostic value of pre-treatment PNH clone among the patients with aplastic anemia: a meta-analysis. Hematology. 2023;28:2204617.","journal-title":"Hematology"},{"key":"3048_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","volume":"373","author":"T Yoshizato","year":"2015","unstructured":"Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, et al. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med. 2015;373:35\u201347.","journal-title":"N Engl J Med"},{"key":"3048_CR6","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, et al. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Engl J Med. 2017;376:1540\u201350.","journal-title":"N Engl J Med"},{"key":"3048_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R Peffault de Latour","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, et al. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. N Engl J Med. 2022;386:11\u201323.","journal-title":"N Engl J Med"},{"key":"3048_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood.2021012130","volume":"139","author":"BA Patel","year":"2022","unstructured":"Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, et al. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study. Blood. 2022;139:34\u201343.","journal-title":"Blood"},{"key":"3048_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187\u2013207.","journal-title":"Br J Haematol"},{"key":"3048_CR10","unstructured":"[Guidelines for the diagnosis and management of aplastic anemia in China (2022)]. Zhonghua Xue Ye Xue Za Zhi. 2022;43:881-8."},{"key":"3048_CR11","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"3048_CR12","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood.2023020078","volume":"142","author":"RP Hasserjian","year":"2023","unstructured":"Hasserjian RP, Germing U, Malcovati L. Diagnosis and classification of myelodysplastic syndromes. Blood. 2023;142:2247\u201357.","journal-title":"Blood"},{"key":"3048_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01031-9","volume":"14","author":"WH Lee","year":"2024","unstructured":"Lee WH, Lin CC, Tsai CH, Tien FM, Lo MY, Tseng MH, et al. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes\/neoplasms. Blood Cancer J. 2024;14:57.","journal-title":"Blood Cancer J"},{"key":"3048_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jama.2015.9643","volume":"314","author":"JM Klco","year":"2015","unstructured":"Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, et al. Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA. 2015;314:811\u201322.","journal-title":"JAMA"},{"key":"3048_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19:4\u201323.","journal-title":"J Mol Diagn"},{"key":"3048_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/cyto.b.21609","volume":"94","author":"A Illingworth","year":"2018","unstructured":"Illingworth A, Marinov I, Sutherland DR, Wagner-Ballon O, DelVecchio L. ICCS\/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis, reporting and case studies. Cytometry B Clin Cytom. 2018;94:49\u201366.","journal-title":"Cytometry B Clin Cytom"},{"key":"3048_CR17","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2017-02-767731","volume":"130","author":"E Negoro","year":"2017","unstructured":"Negoro E, Nagata Y, Clemente MJ, Hosono N, Shen W, Nazha A, et al. Origins of myelodysplastic syndromes after aplastic anemia. Blood. 2017;130:1953\u20137.","journal-title":"Blood"},{"key":"3048_CR18","doi-asserted-by":"publisher","first-page":"EVIDoa2500171","DOI":"10.1056\/EVIDoa2500171","volume":"5","author":"F Gutierrez-Rodrigues","year":"2026","unstructured":"Gutierrez-Rodrigues F, Groarke EM, Miao R, Shalhoub R, Alemu L, Mizumaki H, et al. Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia. NEJM Evid. 2026;5:EVIDoa2500171.","journal-title":"NEJM Evid"},{"key":"3048_CR19","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.7288.1","volume":"5","author":"L Luzzatto","year":"2016","unstructured":"Luzzatto L. Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria. F1000Res. 2016;5:F1000.","journal-title":"F1000Res"},{"key":"3048_CR20","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014;124:2804\u201311.","journal-title":"Blood"},{"key":"3048_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/ejh.13913","volume":"110","author":"J Li","year":"2023","unstructured":"Li J, Liu X, Zhao X, Yang W, Zhang L, Jing L, et al. Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis. Eur J Haematol. 2023;110:379\u201385.","journal-title":"Eur J Haematol"},{"key":"3048_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1053\/j.seminhematol.2022.08.001","volume":"59","author":"J Durrani","year":"2022","unstructured":"Durrani J, Groarke EM. Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation. Semin Hematol. 2022;59:137\u201342.","journal-title":"Semin Hematol"},{"key":"3048_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1182\/asheducation-2018.1.457","volume":"2018","author":"DV Babushok","year":"2018","unstructured":"Babushok DV. A brief, but comprehensive, guide to clonal evolution in aplastic anemia. Hematol Am Soc Hematol Educ Program. 2018;2018:457\u201366.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3048_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1182\/blood-2016-01-636381","volume":"128","author":"S Ogawa","year":"2016","unstructured":"Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016;128:337\u201347.","journal-title":"Blood"},{"key":"3048_CR25","doi-asserted-by":"publisher","first-page":"7651","DOI":"10.3390\/jcm12247651","volume":"12","author":"HY Kim","year":"2023","unstructured":"Kim HY, Yoo KH, Jung CW, Kim HJ, Kim SH. Genetic Characteristics of Patients with Young-Onset Myelodysplastic Neoplasms. J Clin Med. 2023;12:7651.","journal-title":"J Clin Med"},{"key":"3048_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","volume":"22","author":"O Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH, et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell. 2012;22:180\u201393.","journal-title":"Cancer Cell"},{"key":"3048_CR27","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1182\/blood.2021010958","volume":"138","author":"P Sportoletti","year":"2021","unstructured":"Sportoletti P, Sorcini D, Falini B. BCOR gene alterations in hematologic diseases. Blood. 2021;138:2455\u201368.","journal-title":"Blood"},{"key":"3048_CR28","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1007\/s10238-023-01067-4","volume":"23","author":"L Liu","year":"2023","unstructured":"Liu L, Zhang D, Fu Q, Wang J, Yu J, Chen D, et al. Clinical implications of myeloid malignancy\u2011related somatic mutations in aplastic anemia. Clin Exp Med. 2023;23:4473\u201382.","journal-title":"Clin Exp Med"},{"key":"3048_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood-2024-206215","volume":"144","author":"F Gutierrez-Rodrigues","year":"2024","unstructured":"Gutierrez-Rodrigues F, Groarke EM, Alemu L, Rios O, Quinones Raffo D, Lotter J, et al. Longitudinal Contribution of Distinct Hematopoietic Clones during Marrow Recovery in Immune Aplastic Anemia. Blood. 2024;144:32.","journal-title":"Blood"},{"key":"3048_CR30","doi-asserted-by":"publisher","first-page":"EVIDoa2500174","DOI":"10.1056\/EVIDoa2500174","volume":"5","author":"DE Kaya","year":"2026","unstructured":"Kaya DE, Cook R, Iacobelli S, Napolitani G, Gerlevik S, Seymen N, et al. Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag. NEJM Evid. 2026;5:EVIDoa2500174.","journal-title":"NEJM Evid"},{"key":"3048_CR31","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/s41375-022-01636-8","volume":"36","author":"EM Groarke","year":"2022","unstructured":"Groarke EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, Desai P, Leuva H, et al. Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia. Leukemia. 2022;36:2328\u201337.","journal-title":"Leukemia"},{"key":"3048_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1200\/JCO.22.00710","volume":"41","author":"C Gurnari","year":"2023","unstructured":"Gurnari C, Pagliuca S, Prata PH, Galimard JE, Catto LFB, Larcher L, et al. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. J Clin Oncol. 2023;41:132\u201342.","journal-title":"J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03048-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:36:14Z","timestamp":1788417374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03048-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":32,"alternative-id":["3048"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03048-4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors disclose that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Patient consent was waived due to the retrospective nature of the study, which involved the analysis of existing medical records. The study adhered to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}